Pharmafile Logo
Pharmafocus logo
Advanced Search

Impax

Showing 6 posts of 6 posts found.

shutterstock_92671375

Impax agrees to $35 million settlement over anticompetitive practices with Valeant generic

March 12, 2018
Sales and Marketing Impax, Medicis, Solodyn, Valeant, generic, pharma

Impax Pharmaceuticals has acquiesced to paying a $35 million settlement in order to resolve part of an antitrust lawsuit it …

News
teva_copy

Impax to acquire Teva, Allergan generic drugs for $586 million

June 22, 2016
Research and Development, Sales and Marketing Allergan, Impax, Teva, generics

Impax Laboratories (NASDAQ: IPXL) has announced that it has entered into agreements with Teva and affiliates of Allergan to acquire …

News
Impax labs image

Impax cuts staff at troubled California plant

June 11, 2013
Manufacturing and Production FDA, Impax, Rytary

US generic drugmaker Impax Laboratories has said it plans to axe a tenth of its workforce and transfer production away …

News
FDA image

Impax hit by FDA re-inspection failure

March 11, 2013
Manufacturing and Production Impax, hayward

Impax Laboratories has been hit by the news that another (FDA inspection of its troubled manufacturing facility in Hayward, California, …

News
Shire image

Shire pays Impax $48 million

February 12, 2013
Sales and Marketing ADHD, Adderall, Impax, Shire

Shire has paid $48 million to settle a long-running legal spat with Impax Laboratories over Shire’s supply of an authorised …

News
Shire image

Generic approval for Shire’s hyperactivity drug

June 26, 2012
Sales and Marketing ADHD, Adderall XR, FDA, IMS Health, Impax, Shire, Teva

US regulators have delivered a blow to Shire by allowing Actavis Group to produce a generic version of its hyperactivity …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025